Tafamidis generic name?

See the DrugPatentWatch profile for Tafamidis

What is the generic name for Vigdren?

Vigdren, a medication used to treat transthyretin amyloidosis, is known by its generic name Tafamidis.

The use of Tafamidis for this condition has been patented, but its availability in generic form may differ in various regions and countries.

According to DrugPatentWatch.com [1], the patent for Tafamidis has expired, but the availability of generic alternatives may still be limited due to regulatory and manufacturing factors.

When did the patent for Tafamidis expire?

The patent for Tafamidis has expired, allowing for generic versions of the medication to be manufactured and marketed. However, the actual availability of generic Tafamidis may vary depending on factors like country, manufacturer, and regulatory approvals.

Who makes generic Tafamidis?

Several pharmaceutical companies have received regulatory approvals to manufacture and market generic versions of Tafamidis. However, the exact list of generic manufacturers and their availability may be subject to change.

What is Tafamidis used for?

Tafamidis is a medication used to treat transthyretin amyloidosis, a rare genetic disorder that causes abnormal proteins to accumulate in tissues and organs.

References

[1] DrugPatentWatch.com - Patent details for Tafamidis.